<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03409874</url>
  </required_header>
  <id_info>
    <org_study_id>AAMT16</org_study_id>
    <nct_id>NCT03409874</nct_id>
  </id_info>
  <brief_title>Dry Needling and Spinal Manipulation vs. Interocclusal Appliance (Splint), NSAIDs and Joint Mobs for Temporomandibular Dysfunction</brief_title>
  <official_title>Dry Needling and Spinal Manipulation or Interocclusal Appliance (Splint), NSAIDs and Joint Mobs for Temporomandibular Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alabama Physical Therapy &amp; Acupuncture</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad Rey Juan Carlos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alabama Physical Therapy &amp; Acupuncture</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to compare two different approaches for treating patients
      with temporomandibular dysfunction (TMD): Dry needling and spinal manipulation or
      Interocclusal Appliance (Splint), NSAIDs and Temporomandibular Joint Mobilization .
      Clinicians commonly use all of these techniques to treat TMD. This study is attempting to
      find out if one treatment strategy is more effective than the other.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with stress temporomandibular dysfunction will be randomized to receive 1-2
      treatment sessions per week for up to 4 weeks ( up to 8 sessions total) of either: (1) dry
      needling and spinal manipulation or (2) Interocclusal appliance (splint), NSAIDs,
      temporomandibular joint mobilization.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>baseline, 2 weeks, 6 weeks, 3 months</time_frame>
    <description>Change in average jaw pain intensity rated by the patient over last 24 hours and last 7 days (VAS: 0-100mm) between baseline and the following time points: 2 weeks, 6 weeks and 3 months.
Even though patients will be treated 1-2 treatments per week for 4 weeks (up to 8 treatments total), the visual analogue score after 2 weeks of treatment, at 6 weeks (2 weeks post treatment) and at 3 months (2 months post treatment) will be compared to baseline (pre-treatment). Scores closer to 0 represent less pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Rating of Perceived Change</measure>
    <time_frame>2 weeks, 6 weeks, 3 months</time_frame>
    <description>Global rating of perceived change rated rated by the patient according to a -7 to +7 scale. More specifically, the Global Rating of Perceived Change is rated as follows:
A very great deal worse (-7)
A great deal worse (-6)
Quite a bit worse (-5)
Moderately worse (-4)
Somewhat worse (-3)
A little bit worse (-2)
A tiny bit worse (almost the same) (-1)
About the same (0)
A very great deal better (+7)
A great deal better (+6)
Quite a bit better (+5)
Moderately better (+4)
Somewhat better (+3)
A little bit better (+2)
A tiny bit better (almost the same) (+1)
The patient will choose a rating (the closer to +7, the better the score / the closer to -7, the worse the score) after 2 weeks of treatment, at 6 weeks (2 weeks post-treatment) and 3 months (2 months post-treatment).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Active Pain Free Mouth Opening</measure>
    <time_frame>baseline, 2 weeks, 6 weeks, 3 months</time_frame>
    <description>Change in the distance between upper and lower central incisors after patient has opening mouth &quot;as wide as possible&quot; without causing pain between baseline and the following time points: 2 weeks, 6 weeks and 3 months. Measurements will be taken in mm. The greater the distance, the better the score.
Even though patients will be treated 1-2 treatments per week for 4 weeks (up to 8 treatments total), active pain free mouth opening after 2 weeks of treatment, at 6 weeks (2 weeks post treatment) and at 3 months (2 months post treatment) will be compared to baseline (pre-treatment)
Greater scores represent greater pain free mouth opening.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Temporomandibular Joint Dysfunction Syndrome</condition>
  <arm_group>
    <arm_group_label>Dry Needling and Spinal Manipulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Interocclusal Appliance, NSAIDs and TMJ Mobs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dry Needling</intervention_name>
    <description>Dry needling to the muscle of mastication and temporomandibular joint capsule. 1-2 treatment sessions per week for up to 4 weeks</description>
    <arm_group_label>Dry Needling and Spinal Manipulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spinal manipulation</intervention_name>
    <description>Spinal manipulation, targeting the upper cervical spine (C1-C2, C2-C3 or OA). 1-2 treatments per week for up to 4 weeks.</description>
    <arm_group_label>Dry Needling and Spinal Manipulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interocclusal Appliance</intervention_name>
    <description>Interocclusal appliance worn every nights for 4 weeks.</description>
    <arm_group_label>Interocclusal Appliance, NSAIDs and TMJ Mobs</arm_group_label>
    <other_name>splint</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NSAIDs</intervention_name>
    <description>diclofenac (Voltaren) 3 X 50mg per day for 4 weeks. If the patient's TMJ pain improves, the dosage may be reduced to 2 X 50mg per day.</description>
    <arm_group_label>Interocclusal Appliance, NSAIDs and TMJ Mobs</arm_group_label>
    <other_name>diclofenac</other_name>
    <other_name>Voltaren</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TMJ Mobs</intervention_name>
    <description>Temporomandibular joint mobilization targeting the temporomandibular joint capsule. 1-2 treatments per week for up to 4 weeks.</description>
    <arm_group_label>Interocclusal Appliance, NSAIDs and TMJ Mobs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients at least 18 years old

          2. Patient referred to physical therapy from a physician or dentist with a diagnosis of
             temporomandibular dysfunction that is consistent with the Revised TMD Group 1 Muscle
             Disorders Diagnostic Algorithm. (Dworkin et al.1992; Look et al., 2010]. According to
             Blanco-Hungria et al. (2015), this category represents 88.7% of patients with TMD.

          3. History of symptoms related to TMD for at least 3 months

          4. Intensity of pain related to TMD at least 30mm out 100 per Visual Analogue scale (La
             Touche et al, 2009; Gonzalez-Ingesias et al., 2013)

          5. Patient presents with the following: (Gonzalez Perez et al., 2015)

               1. Strong pain in the anterior part of the lower belly of the LPM on palpation

               2. Deep-seated pain in the TMJ and/or region of the maxillary sinus (referred pain)

               3. Significant motor dysfunction (e.g. limited jaw opening, painful protrusion of
                  the chin against resistance, mandibular lateralization to the opposite side upon
                  opening).

        Exclusion Criteria:

          1. Report of red flags to manual physical therapy to include: severe hypertension,
             infection, ankylosing spondylitis, neoplasm, uncontrolled diabetes, peripheral
             neuropathy, heart disease, stroke, chronic, ischemia, edema, severe varicosities,
             tumor, metabolic disease, prolonged steroid use, fracture, RA, osteoporosis, severe
             vascular disease, malignancy, etc.

          2. Signs or symptoms of disc displacement, arthrosis or arthritis of the
             temporomandibular joint according to category II and III of the Research Diagnostic
             Criteria for Temporomandibular Disorders

          3. History of traumatic injury such as a fracture or whiplash

          4. Concomitant diagnosis of any primary headache (i.e. tension type headache or Migraine)
             except cervicogenic headaches

          5. History of surgery related to TMD

          6. Diagnosis of fibromyalgia

          7. Systemic disease such as RA, lupus erythematosus or psoriatic arthritis

          8. Presence of neurological disorder such as trigeminal neuralgia

          9. History of PT, acupuncture or splint treatment within 3 months of the study

         10. History of taking prescription NSAIDs within 3 months of the study

         11. History of regularly taking non-prescription NSAIDs (i.e. more than intermittent)
             within 3 months of the study

         12. Known sensitivity to acetylsalicylic acid, with impaired coagulation or with ulcer,
             kidney or liver problems.

         13. Cadiac pacemaker, metal allergy or severe needle phobia

         14. Serious cardiovascular, cerebral disease, psychiatric disorder or cognitive Impairment

         15. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Dunning, DPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>American Academy of Manipulative Therapy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James Dunning, DPT</last_name>
    <phone>801-707-9056</phone>
    <email>jamesdunning@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raymond Butts, DPT</last_name>
    <phone>803-422-3954</phone>
    <email>fellowship@spinalmanipulation.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Physiomed-lab</name>
      <address>
        <city>Thessalon√≠ki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2018</study_first_submitted>
  <study_first_submitted_qc>January 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2018</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alabama Physical Therapy &amp; Acupuncture</investigator_affiliation>
    <investigator_full_name>James Dunning, DPT, MSc, FAAOMPT</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

